Literature DB >> 8636830

Cisapride-induced long QT interval.

M B Lewin1, R M Bryant, A L Fenrich, R G Grifka.   

Abstract

A 2-month-old infant with gastroesophageal reflux was treated with cisapride. Bradycardia developed and an electrocardiogram revealed 2:1 atrioventricular conduction and a prolonged QT interval. After cessation of cisapride therapy, both the rhythm and the QT interval returned to normal. Prolonged QT interval during treatment with cisapride may occur in children as in adults.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8636830     DOI： 10.1016/s0022-3476(96)70409-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  17 in total

1.  How accurately can QT interval be measured in newborn infants?

Authors:  Katya De Groote; Bert Suys; An Deleeck; Daniël De Wolf; Dirk Matthys; Bart Van Overmeire
Journal:  Eur J Pediatr       Date:  2003-10-10       Impact factor: 3.183

2.  Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.

Authors:  J A Zix; H F Geerdes-Fenge; M Rau; J Vöckler; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease.

Authors:  Y Preechagoon; B Charles; V Piotrovskij; T Donovan; A Van Peer
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

4.  Effects of cisapride on QTc interval in neonates.

Authors:  S Bernardini; D S Semama; F Huet; C Sgro; J B Gouyon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

5.  Randomised controlled trial of cisapride in preterm infants.

Authors:  R J McClure; J H Kristensen; A Grauaug
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

6.  Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial.

Authors:  A Lander; R Redkar; G Nicholls; A Lawson; S R Choudhury; J J Corkery; P Gornall; R G Buick; I W Booth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

7.  Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance.

Authors:  Michael Perrio; Simon Voss; Saad A W Shakir
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias.

Authors:  J R Giudicessi; M J Ackerman; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2018-02-14       Impact factor: 3.598

9.  Randomised controlled trial of cisapride in feed intolerance in preterm infants.

Authors:  A Enriquez; S Bolisetty; S Patole; P A Garvey; P J Campbell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

10.  QT interval prolongation in future SIDS victims: a polysomnographic study.

Authors:  Patricia Franco; José Groswasser; Sonia Scaillet; Jean-Pol Lanquart; Abraham Benatar; Jean-Pierre Sastre; Philippe Chevalier; Béatrice Kugener; André Kahn; Jian-Sheng Lin
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.